LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 60.18 | 17.25 | 1092 | 5031 | 0.2170 | 0.6596 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 63.15 | 17.25 | 866 | 5061 | 0.1711 | 0.6125 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 63.15 | 17.25 | 888 | 5061 | 0.1755 | 0.6174 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 63.15 | 17.25 | 55 | 5061 | 0.0109 | 0.1519 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 63.15 | 17.25 | 1053 | 5061 | 0.2081 | 0.6514 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 65.12 | 17.25 | 874 | 5095 | 0.1715 | 0.6134 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 65.12 | 17.25 | 891 | 5095 | 0.1749 | 0.6171 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 65.12 | 17.25 | 58 | 5095 | 0.0114 | 0.1592 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 65.12 | 17.25 | 1000 | 5095 | 0.1963 | 0.6401 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 67.09 | 17.25 | 862 | 5221 | 0.1651 | 0.6074 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 67.09 | 17.25 | 880 | 5221 | 0.1686 | 0.6114 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 67.09 | 17.25 | 56 | 5221 | 0.0107 | 0.1536 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 67.09 | 17.25 | 1047 | 5221 | 0.2005 | 0.6457 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 69.06 | 17.25 | 878 | 5242 | 0.1675 | 0.6104 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 69.06 | 17.25 | 895 | 5242 | 0.1707 | 0.6142 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 69.06 | 17.25 | 58 | 5242 | 0.0111 | 0.1584 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 69.06 | 17.25 | 1078 | 5242 | 0.2056 | 0.6510 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 71.03 | 17.25 | 876 | 5367 | 0.1632 | 0.6068 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 71.03 | 17.25 | 891 | 5367 | 0.1660 | 0.6101 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 71.03 | 17.25 | 57 | 5367 | 0.0106 | 0.1553 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 71.03 | 17.25 | 1070 | 5367 | 0.1994 | 0.6461 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 73.00 | 17.25 | 877 | 5546 | 0.1581 | 0.6027 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 73.00 | 17.25 | 897 | 5546 | 0.1617 | 0.6070 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 73.00 | 17.25 | 55 | 5546 | 0.0099 | 0.1494 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 73.00 | 17.25 | 1210 | 5546 | 0.2181 | 0.6659 | MN20160310_N02 | M17 |